Biolase, Inc. · OTC:BIOLQ
Biolase — Rodman & Renshaw Annual Global Investment Conference 2012
23 slides from Biolase's conference presentation, Sep 12, 2012
Slide 1: Rodman & Renshaw Annual Global Investment Conference
Exhibit 99.1 Federico Pignatelli, Chairman & CEO September 11, 2012 Rodman & Renshaw Annual Global Investment Conference Nasdaq: BIOL The BIOLASE Total Solution PAGE 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement Thispresentation maycontainforward-looking statements thatarebasedonourcurrentexpectations, estimatesand projectionsaboutour industryas well as management’s beliefsand assumptions. Wordssuchas “anticipates,” “expects,”“intends,”“plans,”“believes,”“seeks,”“estimates,” “may,”“wil
Slide 3: BIOLASE is Revolutionizing Surgery in Dentistry and Medicine Through the Science of Waterlase
BIOLASEisRevolutionizing SurgeryinDentistryand MedicineThroughtheScienceofWaterlase What is Waterlase? • BIOLASE has invented and optimized a biological method to cut tissue • Waterlase is a biological method to cut tissue with very little trauma or bleeding. • The energy from our laser interacts wi
Slide 4: BIOLASE: Company Overview
BIOLASE: Company Overview • BIOLASE is a medical technology company that develops, manufactures, and markets dental lasers. • BIOLASE also markets and distributes dental imaging equipment, intra-oral scanners, and other products designed for procedures in dentistry and medicine. • 2011 GAAP revenue
Slide 5: BIOLASE: Key Milestones
BIOLASE: Key Milestones 1998FDA clearance received for all-tissue Waterlase technology; began selling Waterlase. 2004Introduced the ezLase, our first soft-tissue diode laser. 2006Released the Waterlase MD Turbo, a significant advance in our technology. 2006Entered into exclusive distribution agreeme
Slide 6: Chart & Financial History
Chart & Financial History The BIOLASE Total Solution PAGE 6
Slide 7: Traditional Dentistry
Traditional Dentistry Cavadenti, The Tooth Puller, by Caravaggio, circa 1608 The BIOLASE Total Solution PAGE 7
Slide 8: BIOLASE: the World Leader in Laser Dentistry
BIOLASE: the World Leader in Laser Dentistry …with over 20,000 lasers sold worldwide, including our revolutionary Waterlase iPlus, which was launched in Q1 2011: The iPlus features an The aiming beam on intuitive, touch-based the Waterlase does computer screen, not cut the tissue or similar to a tab
Slide 9: Current Line of BIOLASE Products
Current Line of BIOLASE Products All-tissue dental lasers: Our all-tissue lasers include our flagship laser, the revolutionary Waterlase iPlus, and the new Waterlase MDX 450 and 300. Diodesoft-tissue dentallasers:Oursofttissuelasersinclude the revolutionary iLase, a portable diode laser with no foot
Slide 10: How It Works: Waterlase High Speed Cutting
How It Works: Waterlase High Speed Cutting The BIOLASE Total Solution PAGE 10
Slide 11: Waterlase: Side by Side with Drill
Waterlase: Side by Side with Drill The BIOLASE Total Solution PAGE 11
Slide 12: Waterlase: Soft Tissue Lingual Frenectomy
Waterlase: Soft Tissue Lingual Frenectomy The BIOLASE Total Solution PAGE 12
Slide 13: $50B to $100B Waterlase Market Opportunity
$50B to $100B Waterlase Market Opportunity Global market opportunity is immense…because the dental community is the largest medical community in the world. Our market penetration is approximately 5% of dental practices in the US and approximately 1% internationally. 1 • 176,000 dentists in the US an
Slide 14: BIOLASE's Dominant Market Position
BIOLASE’s Dominant Market Position Owning BIOLASE means owning the hard-tissue dental laser market… 80% BIOLASE Source: BIOLASE Technology Licensing Reports The BIOLASE Total Solution PAGE 14
Slide 15: BIOLASE's Dominant Market Position
BIOLASE’s Dominant Market Position …and the overall dental laser market. 45% BIOLASE Source: iData Research Inc. The BIOLASE Total Solution PAGE 15
Slide 16: BIOLASE's Extensive Patent Portfolio
BIOLASE’s Extensive Patent Portfolio CurrentStatus:BIOLASEhasa tremendous IPportfoliowith285issuedandpendingpatents,70%of which are related to our core Waterlase (Er,Cr:YSGG) technology and medical lasers. Issued & Active Pending Total U.S. 81 52 133 International 81 77 158 Total 162 129 291 • Filin
Slide 17: How Waterlase is Changing Dentistry
How Waterlase is Changing Dentistry • Pain free in the majority of cases: – With no anesthesia, Waterlase increases efficiency and allows the dentist to work in multiple quadrants in a single visit. • Less damage to the surrounding tissue. • Speed of the laser now matches a high-speed drill, for the
Slide 18: Eliminating the Risk of Cross Contamination
Eliminating the Risk of Cross Contamination BIOLASE’S Waterlase technology essentially eliminates the risk of cross contamination and contagion: Waterlase MD™reduced E. faecalis 2.86 Waterlase Tips:times more effectively than NaOCl³ Burs and Endo Files: • Smooth tip surface does not harbor debris or
Slide 19: Pursuing More Opportunities to Expand in Dentistry
Pursuing More Opportunities to Expand in Dentistry Patented laser toothbrush for home use: • Development underway with The Proctor and Gamble Company to develop a laser toothbrush for home use that has the capability to whiten teeth, disinfect teeth and gums, bio-stimulate teeth and gums, and reliev
Slide 20: Opportunities to Expand Beyond Dentistry
Opportunities to Expand Beyond Dentistry With our patented Waterlase and diode technologies, we have created technological platforms thathavetheabilitytoextendbeyonddentistry: Ophthalmology: Wehold14issuedand19pendingU.S.andInternational patentsin fourpatentfamilies in the field of ophthalmology, gi
Slide 21: Opportunities to Expand Beyond Dentistry (Continued)
Opportunities to Expand Beyond Dentistry (Continued) We expect to expand our addressable markets in 2012 and 2013; these potential markets represent multi-billion dollar opportunities. Aesthetics: WehavevariousFDAapprovalsforapplications inoculoplastics, dermatology, andplastic surgery, and are curr
Slide 22: BIOLASE Today
BIOLASE Today • Corporate HQ in Irvine, California • 57,000 sq. ft. facility houses finance & administrative, sales, marketing, customer care, training, manufacturing, and R&D. • Can accommodate growth to $250 million. • ISO 9001 certified and FDA GMP with white-room operations. Company Headquarters
Slide 23: Investment Considerations
Investment Considerations • Ongoing growth in sales and core product line under new distribution model • Addressing $50B-100B market opportunity – Market leader in laser dentistry – Significant potential market opportunities beyond core dental focus • Growth drivers include: – Product improvements a
Biolase — Rodman & Renshaw Annual Global Investment Conference 2012 on 6ix